Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.
Next Steps in Derm‘s most recent installment of Therapeutic Cheat Sheet series covers everything you need to know to start and monitor your patients on IL-17 blocking therapies.
Get more from the JDD - Subscribe today!
You May Also Like
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
